These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 25937637)

  • 1. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
    Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
    Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
    Liu X; Zhang A; Xiang J; Lv Y; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
    Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
    Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatocellular carcinoma growth and angiogenesis by dual silencing of NET-1 and VEGF.
    Wu YY; Chen L; Wang GL; Zhang YX; Zhou JM; He S; Qin J; Zhu YY
    J Mol Histol; 2013 Aug; 44(4):433-45. PubMed ID: 23636606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF.
    Cheng J; Chen Y; Zhao P; Liu X; Dong J; Li J; Huang C; Wu R; Lv Y
    Oncotarget; 2016 May; 7(21):30702-11. PubMed ID: 27120793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of angiogenesis of human umbilical vein endothelial cells by uptake of exosomes secreted from hepatocellular carcinoma cells.
    Yukawa H; Suzuki K; Aoki K; Arimoto T; Yasui T; Kaji N; Ishikawa T; Ochiya T; Baba Y
    Sci Rep; 2018 Apr; 8(1):6765. PubMed ID: 29713019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robo1 promotes angiogenesis in hepatocellular carcinoma through the Rho family of guanosine triphosphatases' signaling pathway.
    Ao JY; Chai ZT; Zhang YY; Zhu XD; Kong LQ; Zhang N; Ye BG; Cai H; Gao DM; Sun HC
    Tumour Biol; 2015 Nov; 36(11):8413-24. PubMed ID: 26022159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion.
    Zou Y; Guo CG; Zhang MM
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4751-61. PubMed ID: 26744866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
    Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotive effects of bone morphogenetic protein 2 on angiogenesis in hepatocarcinoma via multiple signal pathways.
    Zuo WH; Zeng P; Chen X; Lu YJ; Li A; Wu JB
    Sci Rep; 2016 Nov; 6():37499. PubMed ID: 27886213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
    Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
    Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells.
    Tian T; Nan KJ; Wang SH; Liang X; Lu CX; Guo H; Wang WJ; Ruan ZP
    Carcinogenesis; 2010 Jul; 31(7):1211-9. PubMed ID: 20430845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-1 Knockdown Decreases SMMC7721 Human Hepatocellular Carcinoma Cell Invasiveness by Inhibiting Vascular Endothelial Growth Factor-Induced Angiogenesis.
    Zhang ZB; Shi Z; Yang LF; Gao HB
    Can J Gastroenterol Hepatol; 2020; 2020():8880888. PubMed ID: 32676485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.
    Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT
    J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma.
    Cheng N; Li Y; Han ZG
    Hepatology; 2013 May; 57(5):1906-18. PubMed ID: 23258480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argonaute 2 promotes myeloma angiogenesis via microRNA dysregulation.
    Wu S; Yu W; Qu X; Wang R; Xu J; Zhang Q; Xu J; Li J; Chen L
    J Hematol Oncol; 2014 May; 7():40. PubMed ID: 24886719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling.
    Liu P; Atkinson SJ; Akbareian SE; Zhou Z; Munsterberg A; Robinson SD; Bao Y
    Sci Rep; 2017 Oct; 7(1):12651. PubMed ID: 28978924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.
    Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X
    J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.